June 2024 • PharmaTimes Magazine • 4-5
Contents
Features
Analysis
SmartPeople
13.
New age
Introducing, Freddie Lewis – Medical Director at Havas Lynx Group
16.
Rare disease clinical trials
Why a global approach can accelerate innovation
21.
Maximising success
Navigating regulatory and safety hurdles in global clinical trials
22.
Activated patient conundrum
Patient-centricity, involvement or engagement?
23.
Time trials
Paradigm shift in collaborative academia-industry clinical trials
36.
You got the moves
Where you are going and what you're going to do when you're there
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.